ROCKET PHARMA

Serial Number 98399453
730

Registration Progress

Application Filed
Feb 9, 2024
Under Examination
Apr 29, 2025
Approved for Publication
Mar 4, 2025
Published for Opposition
Mar 4, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Apr 29, 2026 99 days

Trademark Image

ROCKET PHARMA

Basic Information

Serial Number
98399453
Filing Date
February 9, 2024
Published for Opposition
March 4, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
730
Status Date
Oct 29, 2025
Application
Pending
Classes
005 042 044

Rights Holder

Rocket Pharmaceuticals GmbH

27
Address
Industriestrasse 47
Zug 6300
CH

Ownership History

Rocket Pharmaceuticals GmbH

Original Applicant
27
Zug CH

Rocket Pharmaceuticals GmbH

Owner at Publication
27
Zug CH

Legal Representation

Attorney
Danny M. Awdeh

USPTO Deadlines

Next Deadline
99 days remaining
NOA E-Mailed - SOU Required
Due Date
April 29, 2026
Extension Available
Until October 29, 2026

Application History

25 events
Date Code Type Description Documents
Oct 30, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 29, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 29, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 29, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 29, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 4, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 5, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 5, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 5, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 5, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 5, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 15, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 15, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 15, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 3, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Dec 3, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Sep 3, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 3, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 3, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 3, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 10, 2024 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 10, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 9, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of genetic diseases and disorders
Class 042
Research and development of pharmaceuticals for the treatment of genetic diseases and disorders; medical and scientific research services in the field of genetic disease and disorder treatment
Class 044
Providing medical and health information in the field of genetic diseases and disorders; providing information in the field of genetic diseases and disorders treatment for medical purposes; Providing links to the web sites of others featuring medical and health information about genetic diseases and disorders; providing links to the web sites of others featuring information about the diagnosis and treatment of genetic diseases and disorder

Additional Information

Design Mark
The mark consists of the stylized wording "ROCKET PHARMA" with the term "ROCKET" in black and the term "PHARMA" in grey. To the left of the wording is a cluster of five hexagons. The top four hexagons appear in red. The bottom hexagon appears in white outlined in red.
Color Claim
The color(s) white, red, black, and grey is/are claimed as a feature of the mark.
Pseudo Mark
ROCKET PHARMACEUTICALS

Classification

International Classes
005 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"